THIS EVENT BEGINS IN...

  • 00Days
  • 00Hours
  • 00Minutes
  • 00Seconds

The Lytham Partners Investor Healthcare Summit is a premier virtual event bringing together leading public healthcare companies for curated webcasts, offering the opportunity to hear from top executives through engaging fireside chats. These sessions will highlight topics such as company performance, innovative developments, and provide key insights into the healthcare sector’s outlook and opportunities for 2025.

Questions?

If you have any questions about this event or future investor conferences, please complete the form below and a member of our team will be in touch shortly.

Arianne Phosphate

TSXV: DAN / OTCQX: DRRSF

Basic Materials

Guanajuato Silver

TSXV: GSVR / OTCQX: GSVRF

Basic Materials

Ur-Energy USA Inc.

NYSE American: URG / TSX: URE

Basic Materials

Charles & Colvard Logo

Charles & Colvard

NASDAQ: CTHR

Consumer

Else Nutrition Holdings

TSXV: BABY / OTCQX: BABYF

Consumer

Flow Beverage Corp.

TSX: FLOW / OTCQX: FLWBF

Consumer

Parks! America, Inc.

PINK: PRKA

Consumer

The Planting Hope Company

TSXV: MYLK / OTCQB: MYLKF

Consumer

Acasti Pharma

NASDAQ: ACST

Healthcare

Aurora Spine Corp.

TSXV: ASG / OTCQB: ASAPF

Healthcare

Cadrenal Therapeutics

NASDAQ: CVKD

Healthcare

ChromaDex Corporation

NASDAQ: CDXC

Healthcare

Delcath Systems

NASDAQ: DCTH

Healthcare

Hydreight Technologies

TSXV: NURS / OTCQB: HYDTF

Healthcare

ImmuCell Corp.

NASDAQ: ICCC

Healthcare

INVO Bioscience

NASDAQ: INVO

Healthcare

Jaguar Health, Inc.

NASDAQ: JAGX

Healthcare

Lantern Pharma

NASDAQ: LTRN

Healthcare

LifeMD, Inc.

NASDAQ: LFMD

Healthcare

OpSens Inc.

TSX: OPS / OTCQX: OPSSF

Healthcare

Perimeter Medical Imaging

TSXV: PINK / PINK: PYNKF

Healthcare

Quipt Home Medical

NASDAQ: QIPT / TSXV: QIPT

Healthcare

Reliq Health Technologies

TSXV: RHT / PINK: RQHTF

Healthcare

Reviva Pharmaceuticals

NASDAQ: RVPH

Healthcare

Scientific Industries, Inc.

OTCQB: SCND

Healthcare

Sensus Healthcare

NASDAQ: SRTS

Healthcare

Shuttle Pharmaceuticals

NASDAQ: SHPH

Healthcare

Trinity Biotech plc

NASDAQ: TRIB

Healthcare

VolitionRx Limited

NYSE American: VNRX

Healthcare

Zomedica

NYSE American: ZOM

Healthcare

374Water

NASDAQ: SCWO

Industrials

Canoo

NASDAQ: GOEV

Industrials

Civeo Corporation

NYSE: CVEO

Industrials

Coda Octopus Group

NASDAQ: CODA

Industrials

L.B. Foster Company

NASDAQ: FSTR

Industrials

Limbach Holdings, Inc.

NASDAQ: LMB

Industrials

LiqTech International, Inc.

NASDAQ: LIQT

Industrials

NaaS Technology, Inc.

NASDAQ: NAAS

Industrials

Northern Technologies Intl.

NASDAQ: NTIC

Industrials

S&W Seed Company

NASDAQ: SANW

Industrials

SenesTech, Inc.

NASDAQ: SNES

Industrials

Tecnoglass, Inc.

NASDAQ: TGLS

Industrials

Anterix

NASDAQ: ATEX

Technology

Climb Global Solutions

NASDAQ: CLMB

Technology

GSE Systems, Inc.

NASDAQ: GVP

Technology

HUB Cyber Security

NASDAQ: HUBC

Technology

LiveWorld, Inc.

PINK: LVWD

Technology

Loop TV

NYSE American: LPTV

Technology

Mogo, Inc.

TSX: MOGO / NASDAQ: MOGO

Technology

One Stop System

NASDAQ: OSS

Technology

Precision Optics Corp.

NASDAQ: POCI

Technology

SOBR Safe, Inc.

NASDAQ: SOBR

Technology

The Glimpse Group, Inc.

NASDAQ: VRAR

Technology

Wishpond Technologies

TSXV: WISH / OTCQX: WPNDF

Technology

Zoomd Technologies

TSXV: ZOMD / OTC: ZMDTF

Technology

Acasti Pharma

NASDAQ: ACST

Healthcare

Cadrenal Therapeutics

NASDAQ: CVKD

Healthcare

Hydreight Technologies

TSXV: NURS / OTCQB: HYDTF

Healthcare

Jaguar Health

NASDAQ: JAGX

Healthcare

Lantern Pharma

NASDAQ: LTRN

Healthcare

Reviva Pharmaceuticals

NASDAQ: RVPH

Healthcare

Shuttle Pharmaceuticals

NASDAQ: SHPH

Healthcare

Zomedica

NYSE American: ZOM

Healthcare

Else Nutrition Holdings

TSXV: BABY / OTCQX: BABYF

Consumer

Flow Beverage Corp.

TSX: FLOW / OTCQX: FLWBF

Consumer

Parks! America, Inc.

PINK: PRKA

Consumer

L.B. Foster Company

NASDAQ: FSTR

Industrials

SenesTech

NASDAQ: SNES

Industrials

Tecnoglass

NASDAQ: TGLS

Industrials

LiveWorld, Inc.

PINK: LVWD

Technology

Precision Optics Corp.

NASDAQ: POCI

Technology

SOBR Safe, Inc.

NASDAQ: SOBR

Technology

may 18th | 8AM ET

Future Shock: Navigating the Evolving Economy for Small Companies

Explore the trajectory of the economy and its implications for small businesses in this keynote address. 

This event will be moderated by Roger Weiss, Vice President, Lytham Partners and panelists include:

  • Art Hogan, Managing Director & Chief Market Strategist, B. Riley Wealth
  • Ryan Detrick, Chief Market Strategist, The Carson Group

may 18th | 11AM ET

Advancements in the Fight Against Cancer: Innovations in Cancer Treatment

Delve into groundbreaking technologies, medical devices, and pharmaceuticals in various stages of development to combat cancer.

This event will be moderated by Ben Shamsian, Vice President, Lytham Partners and panelists include:

  • Gerard Michel, CEO of Delcath Systems, Inc.
  • Anatoly Dritschilo, CEO of Shuttle Pharmaceuticals

may 18th | 11AM ET

Social Media: Where Do We Go From Here?: Mapping the Future Landscape

Examine the present usage of social media and embark on an exploration of its future implications in this engaging panel discussion.

This event will be moderated by Adam Lowensteiner, Vice President, Lytham Partners and panelists include:

  • Peter Friedman, Chairman, CEO and Founder of LiveWorld, Inc.
  • Eddie Geller, CEO of TinyBeans

may 18th | 2pM ET

Revolutionizing Healthy Nutrition: Latest Innovations for a Nourishing Future

Discover the cutting-edge advancements in healthy nutrition as three companies redefine the landscape, from infant nutrition to adult snacking and beyond.

This event will be moderated by Ben Shamsian, Vice President, Lytham Partners and panelists include:

  • Mike Morris, CEO of Perfect Keto
  • Julia Stamberger, Founder and CEO of The Planting Hope Company
  • Hamutal Yitzhak, Founder and CEO of Else Nutrition

may 18th | 2PM ET

Phase 3 Drugs to Watch: Exploring Promising Companies at the Vanguard of Clinical Trials

Engage in a captivating discussion with companies pioneering their way through pivotal Phase 3 clinical trials.

This event will be moderated by Robert Blum, Managing Partner, Lytham Partners and panelists include:

  • Laxminarayan Bhat, PhD, CEO of Reviva Pharmaceuticals
  • Prashant Kohli, CEO of Acasti Pharma
  • Quang Pham, CEO of Cadrenal Therapeutics

may 18th | 5PM ET

The State of Animal Health: Trends and Strategies for Pet Owners and Veterinarians

Gain insights into current trends in the animal health industry and learn how companies are meeting the evolving needs of pets, pet owners, and veterinarians.

This event will be moderated by Joe Diaz, Managing Partner, Lytham Partners and panelists include:

  • Tom Butera, CEO of Volition Vet (a division of VolitionRx)
  • Lisa Conte, CEO of Jaguar Health
  • Larry Heaton, CEO of Zomedica

investor Registration

Thank you for expressing interest in attending our Healthcare Summit! Complete the form below and you will be added as an investor attendee.

This field is for validation purposes and should be left unchanged.

Contact us

Complete the form below and a member of our team will reach out shortly.

This field is for validation purposes and should be left unchanged.

Jack has more than 20 years of experience in investor relations, FP&A as well as equity research roles at Wall Street firms. He provides clients with investor relations counsel and strategy, as well as support for quarterly earnings and investor and analyst targeting programs. Previously, Jack was a senior vice president in the corporate communications practice at Finn Partners and an executive at a large cap publicly traded retail company.

Roger Weiss is a highly regarded member of the Wall Street institutional sales community. In a career spanning more than 30 years, he has held senior sales management positions at leading sell-side firms including B. Riley/National Securities, Canaccord Genuity, A.G. Edwards, and First Manhattan Co. He also has extensive commercial banking experience serving at J.P. Morgan Chase (Manufacturers Hanover Trust) and PNC Financial. Roger holds a Bachelor of Arts degree from Vanderbilt University and an MBA, with concentrations in Accounting and Finance from the Columbia Business School.

Ben Shamsian has been an equities analyst on the buyside and sell side for over thirteen years. Prior to joining Lytham, Ben was a senior analyst at FNY Capital, Sterne Agee and Iridian Asset Management, where he covered consumer, industrial, technology, energy, and business services sectors. Ben has expertise in uncovering the value of equities through financial modeling, management interviews, and industry research. Throughout his career, many management and investor relations teams have seeked Ben’s advice as to how to better communicate with their investors. Ben began his career in accounting with PWC and Merrill Lynch, and obtained his CPA license. Ben holds a BS in Accounting from Yeshiva University and an MBA in Finance from New York University’s Stern School of Business.

Adam Lowensteiner has been closely involved with micro and small-cap companies his entire career. Prior to joining Lytham, Adam was a Senior Account Executive at Wolfe Axelrod Weinberger Associates, an investor relations agency based in New York City. For thirteen years Adam worked intimately with the CEOs and CFOs of emerging growth companies seeking to expand the investor audience base. Prior to working at Wolfe Axelrod Weinberger, Adam worked as a sellside analyst with CJS Securities in White Plains, New York, as a generalist, but focused on small cap stocks. Prior to CJS, Adam worked several years with Individual Investor Group in New York City as a Senior Research Analyst, mostly researching micro and small cap ideas for the company’s various publications and investment vehicles. Adam graduated from the Sy Syms School of Business at Yeshiva University with a Bachelors of Science in Finance.

Rolf has worked in the investor relations field for more than 15 years.  He is responsible for gathering research materials and assisting in the organization of materials for road shows and 1×1 meetings.  His focus is on researching and data analysis at the institutional level.  Prior to that, he worked with international commerce.  He holds degrees from the University of Iowa.

Brittany is a creative and resourceful marketing professional with 10 years of design, social media management and special event experience. She specializes in creating processes for heightened customer journeys through strategic and imaginative print and digital campaigns as well as creating and maintaining strong brands within the organizations she works for. Brittany has worked in a variety of industries in both the public and private sectors including Hospitality & Tourism, Education and Renewable Energy.

Kristen oversees creative programs and design concepts and plays an essential role in the marketing, communications and creative needs of our organization and client companies. For more than 15 years she has been applying her creative talents to developing collateral materials, annual report concepts and design, website design and development, social media and email marketing campaigns, digital and traditional print advertising. Additionally, Kristen manages all aspects of client press release distribution and quarterly earnings event logistics. She has a B.A. degree in English from Marist College and studied Computer Graphic Design at Phoenix College.

Robert Breza’s background includes 30 years of finance and technology experience including 19 years on Wall Street with Tier 1 firms such as the Royal Bank of Canada (RBC) for 10 years and technology focused firms such as Thomas Weisel Partners during the Internet boom and bust in San Francisco and Stern Agee. Rob has worked with large companies such as Microsoft and Oracle and many smaller companies taking 16 companies public (IPO’s). Rob has an MBA from the University of Minnesota – Carlson School of Management and a B.S. in Accounting from St. Cloud State University – Herberger School of Business. Rob resides in Scottsdale, AZ.

In a career spanning more than 25 years Joe Diaz has extensive experience in advising and counseling corporate management teams on operational and valuation issues. He has been instrumental in crafting and executing strategic programs that have yielded significant enhancement of shareholder value –including AdvancePCS (now Caremark Rx, Inc.), Allied Waste, Inc. (NYSE: AW), Bio-Rad Laboratories (AMEX: BIO), CNS, Inc. (NASDAQ: CNXS) and Abaxis, Inc. (NASDAQ: ABAX), among others. With a background in portfolio management Joe maintains a strong belief that investors in the small cap arena are actually “investing” in management teams than can consistently grow businesses, rather than innovative products and services. His primary focus is on establishing and maintaining management credibility. An alumnus of Coe College, Joe, along with his wife Pat, is an avid equestrian, sports fan and free market capitalist.

Joe has a strong track record for the management, design and implementation of strategic plans to enhance shareholder value for leading-edge companies. In a career that spans more than 25 years, he has successfully delivered strategic investor relations services to clients and provides unique insight on quarterly earnings materials, investor conferences, non-deal roadshows, IPOs, and analyst-investor days. Leveraging his extensive knowledge of industry fundamentals and his direct experience with investor decision-making, he has been responsible for overseeing significant capital appreciation for client companies under his direct management. He was previously affiliated with a leading regional investment banking and securities firm and was responsible for initiating and operating the first United Mexican States Federal Treasury Certificate (CETES) desk in Arizona. Joe holds a B.A. degree from Arizona State University.

Robert is a 20-year investor relations industry veteran, with an expertise in understanding the dynamics and requirements of a successful relationship between public companies and the capital markets. During his career, Robert has overseen the development and implementation of every critical component of a successful investor relations campaign, including the execution of thousands of non-deal roadshow meetings, conference 1×1’s and management conference calls as well as other critical investor outreach components such as creation of the firm’s institutional corporate profiles and virtual conference initiatives. His ability to successfully guide his clients corporate positioning resides in his ability to articulate a company’s value proposition through benchmarks and metrics that easily resonate with the national investment community, streamlining these components throughout press releases, conference call scripts, investor presentations, websites, and annual reports. In addition to traditional investor relations activities, Robert has consulted the management and board of directors on a number of capital markets activities, including having guided numerous companies through the uplisting process from the OTC to Nasdaq and/or NYSE, cross listing of shares from a foreign exchange to the U.S., proxy contest situations, capital raise evaluation, merger/acquisition valuation impact, crisis communications, perception analysis, and board of director/management recruitment. Robert spearheaded the campaign and created the relationships that resulted in a client being named “Stock of the Decade” as the #1 performing stock for 2000-2010. An alumnus of Arizona State University, he holds a B.A. degree in Finance.

Request an invite

Thank you for expressing interest in attending our conference! Complete the form below and a member of our team will reach out shortly.

This field is for validation purposes and should be left unchanged.

Request a Free Consultation

We’re excited to meet you! Complete the form below and a member of our team will be in touch.

This field is for validation purposes and should be left unchanged.
Skip to content